ID
42515
Description
Study ID: 106464 Clinical Study ID: 106464 Study Title: A Study of the Efficacy Against Episodes of Clinical Malaria Due to P. Falciparum Infection of GSK Biologicals Candidate Vaccine RTS, S/AS01, Administered According to a 0,1,2-months Schedule in Children Aged 5 to 17 Months Living in Tanzania & Kenya Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00380393 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: GSK malaria vaccine 257049 Vaccine, Sanofi-Pasteur's Human Diploid Cell Rabies Vaccine Trade Name: N/A Study Indication: Malaria ODM derived from https://clinicaltrials.gov/ct2/show/study/NCT00380393. This Phase IIb randomized, double-blind, controlled study of the efficacy against episodes of clinical malaria due to Plasmodium falciparum infection of GlaxoSmithKline Biologicals’ candidate vaccine RTS, S/AS01E, administered IM according to a 0, 1, 2-month vaccination schedule in children aged 5 months to 17 months living in Tanzania and Kenya. This study includes the following 7 clinical study visits (3 different visit types) during a double-blind phase (Day -60 to Month 6 1/2) and a single-blind phase including an extension for a subset of patients (month 7 to month 14). Clinical visit 1: Baseline visit, screening, and randomisation (DAY -60 to 0) Clinical visit 2: Vaccination I (MONTH 0, DAY 0 | DOSE 1 | 0 - 60 DAYS AFTER VISIT 1) Clinical visit 3: Vaccination II (MONTH 1, DAY 30 | DOSE 2 | 21 - 35 DAYS AFTER VISIT 2) Clinical visit 4: Vaccination III (MONTH 2, DAY 60 | DOSE 3 | 21 - 35 DAYS AFTER VISIT 3) Clinical visit 5: Blood Sample, ACD (MONTH 3, DAY 90 | 21 - 42 DAYS AFTER VISIT 4) Clinical visit 6: Blood Sample, ACD (MONTH 6 1/2 | CROSS-SECTIONAL VISIT FOR ACD | FINAL STUDY VISIT FOR DOUBLE-BLIND PHASE) Clinical visit 7: Blood Sample, ACD (MONTH 14 | FINAL STUDY VISIT SINGLE-BLIND PHASE) Field-worker home visits: During the vaccination period, clinical visits are accompanied by daily field-worker visits for a one-week period subsequent to each vaccine administration at clinical visits 2, 3, and 4 (visit code 21-26 following clinical visit 2; visit code 27-32 following clinical visit 3; visit code 33-38 following clinical visit 4). After completion of the vaccination period, clinical visits are then accompanied by weekly field-worker home visits (visit code 39-40 following clinical visit 4/dose 3; visit code 41-55 following clinical visit 5; visit code 56-86 following clinical visit 6). These visits serve the additional purpose of Active Case Detection (ACD). Passive Case Detection (PCD) for clinical malaria disease is performed both during the course of the double-blind (day -60 to month 6 1/2) and the single-blind phase (month 7 to month 14). Laboratory reference range for each laboratory test should be documented in this form. If the reference ranges for any test differ by age range, age units or sex, a separate form for each variation should be completed. Note that informed consent has to be obtained prior to any study procedure.
Lien
https://clinicaltrials.gov/ct2/show/study/NCT00380393
Mots-clés
Versions (1)
- 11/08/2021 11/08/2021 -
Détendeur de droits
GlaxoSmithKline
Téléchargé le
11 août 2021
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY-NC 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Efficacy of P. Falciparum Vaccine Against Malaria in Children NCT00380393
Laboratory Reference Ranges
- StudyEvent: ODM
Description
Laboratory Reference Ranges
Alias
- UMLS CUI-1
- C0883335
Description
Laboratory Reference Ranges
Alias
- UMLS CUI-1
- C0883335
Description
Enter the reference range for each test. If the reference ranges for any test differ by age range, age units or sex, complete a separate version of this repeating item group for each variation (e.g., males 0-16, males 17-99, females 0- 16, females 17-99 years).
Type de données
date
Alias
- UMLS CUI [1,1]
- C0883335
- UMLS CUI [1,2]
- C0011008
Description
Age range low
Type de données
integer
Alias
- UMLS CUI [1,1]
- C0001779
- UMLS CUI [1,2]
- C1514721
- UMLS CUI [1,3]
- C0205251
Description
Age range high
Type de données
integer
Alias
- UMLS CUI [1,1]
- C0001779
- UMLS CUI [1,2]
- C1514721
- UMLS CUI [1,3]
- C0205250
Description
(tick one box) In the original paper-based version of this clinical study report, 'weeks' was pre-selected for this item.
Type de données
integer
Alias
- UMLS CUI [1,1]
- C0001779
- UMLS CUI [1,2]
- C1519795
Description
In the original paper-based version of this clinical study report, 'Male and Female reference range' was pre-selected for this item.
Type de données
integer
Alias
- UMLS CUI [1]
- C0079399
Description
In the original paper-based version of this clinical study report, this item was pre-filled with 5 U/L.
Type de données
integer
Unités de mesure
- U/L
Alias
- UMLS CUI [1]
- C0008000
- UMLS CUI [2,1]
- C1272773
- UMLS CUI [2,2]
- C0201836
Description
In the original paper-based version of this clinical study report, this item was pre-filled with 60 U/L.
Type de données
integer
Unités de mesure
- U/L
Alias
- UMLS CUI [1]
- C0008000
- UMLS CUI [2,1]
- C1299400
- UMLS CUI [2,2]
- C0201836
Description
In the original paper-based version of this clinical study report, this item was pre-filled with 10 µmol/L.
Type de données
integer
Unités de mesure
- µmol/L
Alias
- UMLS CUI [1]
- C0008000
- UMLS CUI [2,1]
- C1272773
- UMLS CUI [2,2]
- C0201975
Description
In the original paper-based version of this clinical study report, this item was pre-filled with 60 µmol/L.
Type de données
integer
Unités de mesure
- µmol/L
Alias
- UMLS CUI [1]
- C0008000
- UMLS CUI [2,1]
- C1299400
- UMLS CUI [2,2]
- C0201975
Description
In the original paper-based version of this clinical study report, this item was pre-filled with 8.0 g/dL.
Type de données
float
Unités de mesure
- g/dL
Alias
- UMLS CUI [1]
- C0018941
- UMLS CUI [2,1]
- C1272773
- UMLS CUI [2,2]
- C0518015
Description
In the original paper-based version of this clinical study report, this item was pre-filled with 18 g/dL.
Type de données
float
Unités de mesure
- g/dL
Alias
- UMLS CUI [1]
- C0018941
- UMLS CUI [2,1]
- C1299400
- UMLS CUI [2,2]
- C0518015
Description
In the original paper-based version of this clinical study report, this item was pre-filled with 4.0 x 10^3/µL
Type de données
float
Unités de mesure
- 10^3/µL
Alias
- UMLS CUI [1]
- C0018941
- UMLS CUI [2,1]
- C1272773
- UMLS CUI [2,2]
- C0023508
Description
In the original paper-based version of this clinical study report, this item was pre-filled with 17 x 10^3/µL
Type de données
float
Unités de mesure
- 10^3/µL
Alias
- UMLS CUI [1]
- C0018941
- UMLS CUI [2,1]
- C1299400
- UMLS CUI [2,2]
- C0023508
Description
In the original paper-based version of this clinical study report, this item was pre-filled with 100 x 10^3/µL
Type de données
integer
Unités de mesure
- 10^3/µL
Alias
- UMLS CUI [1]
- C0018941
- UMLS CUI [2,1]
- C1272773
- UMLS CUI [2,2]
- C0005821
Description
In the original paper-based version of this clinical study report, this item was pre-filled with 800 x 10^3/µL
Type de données
integer
Unités de mesure
- 10^3/µL
Alias
- UMLS CUI [1]
- C0018941
- UMLS CUI [2,1]
- C1299400
- UMLS CUI [2,2]
- C0005821
Similar models
Laboratory Reference Ranges
- StudyEvent: ODM
C0600091 (UMLS CUI [1,2])
C0805701 (UMLS CUI [1,2])
C2347796 (UMLS CUI [2,1])
C0457083 (UMLS CUI [2,2])
C0011008 (UMLS CUI [1,2])
C1514721 (UMLS CUI [1,2])
C0205251 (UMLS CUI [1,3])
C1514721 (UMLS CUI [1,2])
C0205250 (UMLS CUI [1,3])
C1272773 (UMLS CUI [2,1])
C0201836 (UMLS CUI [2,2])
C1299400 (UMLS CUI [2,1])
C0201836 (UMLS CUI [2,2])
C1272773 (UMLS CUI [2,1])
C0201975 (UMLS CUI [2,2])
C1299400 (UMLS CUI [2,1])
C0201975 (UMLS CUI [2,2])
C1272773 (UMLS CUI [2,1])
C0518015 (UMLS CUI [2,2])
C1299400 (UMLS CUI [2,1])
C0518015 (UMLS CUI [2,2])
C1272773 (UMLS CUI [2,1])
C0023508 (UMLS CUI [2,2])
C1299400 (UMLS CUI [2,1])
C0023508 (UMLS CUI [2,2])
C1272773 (UMLS CUI [2,1])
C0005821 (UMLS CUI [2,2])
C1299400 (UMLS CUI [2,1])
C0005821 (UMLS CUI [2,2])